LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "treatments new" as a keyword



Related mechanisms, current treatments, and new perspectives in meningioma

Sign Up to like & get
recommendations! Published in 2024 at "Genes"

DOI: 10.1002/gcc.23248

Abstract: Meningiomas are non‐glial tumors that are the most common primary brain tumors in adults. Although meningioma can possibly be cured with surgical excision, variations in atypical/anaplastic meningioma have a high recurrence rate and a poor… read more here.

Keywords: treatments new; perspectives meningioma; mechanisms current; new perspectives ... See more keywords

Sarcopenia: Current treatments and new regenerative therapeutic approaches

Sign Up to like & get
recommendations! Published in 2020 at "Journal of Orthopaedic Translation"

DOI: 10.1016/j.jot.2020.04.002

Abstract: Sarcopenia is characterized by loss of muscle and reduction in muscle strength that contributes to higher mortality rate and increased incidence of fall and hospitalization in the elderly. Mitochondria dysfunction and age-associated inflammation in muscle… read more here.

Keywords: sarcopenia; treatments new; current treatments; sarcopenia current ... See more keywords

Treatments of new‐onset atrial fibrillation in critically ill patients: a systematic review with meta‐analysis

Sign Up to like & get
recommendations! Published in 2022 at "Acta Anaesthesiologica Scandinavica"

DOI: 10.1111/aas.14032

Abstract: New‐onset atrial fibrillation (NOAF) is common in hospitalised patients with critical illness and associated with worse outcomes. Several interventions are available in the management of NOAF, but the overall effectiveness and safety of these interventions… read more here.

Keywords: atrial fibrillation; onset atrial; fibrillation critically; treatments new ... See more keywords
Photo by nci from unsplash

Laboratory monitoring of hemophilia A treatments: new challenges.

Sign Up to like & get
recommendations! Published in 2020 at "Blood advances"

DOI: 10.1182/bloodadvances.2019000849

Abstract: Monitoring factor VIII (FVIII) activity has traditionally been complicated by discrepancies between assays for the various sorts of FVIII molecules. The advent of novel nonfactor therapies (emicizumab, fitusiran, and anti-tissue factor pathway inhibitor antibodies) in… read more here.

Keywords: treatments new; hemophilia treatments; monitoring hemophilia; laboratory monitoring ... See more keywords